Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies
Samantha Brown(Memorial Sloan Kettering Cancer Center), Priyanka Shivdasani(Brigham and Women's Hospital), Hira Rizvi(Memorial Sloan Kettering Cancer Center), Laura MacConnaill, Priti Kumari, Angela J. Waanders(Lurie Children's Hospital), Matthew D. Ducar(Brigham and Women's Hospital), Benjamin Groß(Memorial Sloan Kettering Cancer Center), Caroline G. McCarthy(Memorial Sloan Kettering Cancer Center), Jean Abraham, Matthew Ingham(Columbia University), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), Margaret Foti, Neal I. Lindeman(Cornell University), Dilrini De Silva, Philippe L. Bédard(Princess Margaret Cancer Centre), Michael V. Fiandalo(University of Kentucky), Jeremy L. Warner(Brown University), Chris Boursnell(University of Cambridge), Jena Lilly(Children's Hospital of Philadelphia), Eva M. Lepisto, James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Ronglai Shen(Memorial Sloan Kettering Cancer Center), Raúl Rabadán(Columbia University Irving Medical Center), Yekaterina B. Khotskaya(University of Alabama at Birmingham), John A. Orechia, Shawn M. Sweeney(American Association For Cancer Research), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Kenneth L. Kehl(Dana-Farber Cancer Institute), Mikel Valgañón, Ethan Cerami, Brooke Mastrogiacomo(Memorial Sloan Kettering Cancer Center), Axel Martin(Memorial Sloan Kettering Cancer Center), Raquel Rodríguez-García(Hospital Universitario Central de Asturias), Birgit Nimmervoll, Marilyn M. Li(Children's Hospital of Philadelphia), Adam Resnick(Children's Hospital of Philadelphia), Richard D. Carvajal(Northwell Health), Jessica A. Lavery(Memorial Sloan Kettering Cancer Center), Deborah Schrag(Dana-Farber Brigham Cancer Center), Carlos Caldas(University of Cambridge), Ben Ho Park(Vanderbilt University Medical Center), Mahdi Sarmardy, Susan Hsaio, Oscar M. Rueda(University of Cambridge), Ezequiel Rodriguez, Katherine S. Panageas(Mayo Clinic)
Cited by 52
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k